PDCD1 and Epstein-Barr virus infection: Recent focus on immunotherapy of GC has also indicated that tumours with EBV infection have a relatively high infiltration of T lymphocytes and PD‐L1 mRNA expression, leading to a good response to anti‐PD1 immunotherapy.18, 19